Announced Tue, 30 Jun · 19:42 IST
Dr. Reddy's informs Exchange about Integrated Annual Report FY 2026
Compliance View source PDF
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.1%1-day move
₹1359.20
prior close
₹1351.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.1+0.2-0.8-1.1+0.9+0.4-0.4-0.6-8.3-13.2———
Up moveDown movePending
AI summary
Dr. Reddy's Laboratories has informed the stock exchange about the release of its Integrated Annual Report for FY 2026. The integrated annual report combines financial and non-financial performance, including ESG disclosures. This is a routine compliance filing under listing requirements.
Likely market impact
Routine compliance filing. No immediate impact on share price. Highlights the company's annual performance and sustainability reporting.